or
Bookmark and Share
Method for the treatment of depression
   
Document Number
US Patent 5246941
Issued Date
September 21, 1993
Link
Inventors
Map
Abstract
The invention relates to the use of compounds which act as antagonists of 5-hydroxytryptamine (5-HT) at 5-HT.sub.3 receptors for the treatment of depression.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
1
Comments:
no comments yet
Owner
Glaxo Group Limited (London,GB2)
Published
September 21, 1993
Application Number
08/005,125
Filed
January 15, 1993
US Classification
514/299  
Int'l Classification
A61K   31/55   (20060101)   A61K   31/46   (20060101)   A61K   31/50   (20060101)   A61K   31/445   (20060101)   A61K   31/415   (20060101)  
Examiner
Attorney/Law Firm
Parent Case
This application is a division of application Ser. No. 07/912,337, filed Jul. 13, 1992, which is a continuation of application Ser. No. 07/723,264 filed Jun. 28, 1991, now abandoned, which is a continuation of application Ser. No. 07/522,321, filed May 11, 1990, now abandoned, which is a divisional application of application Ser. No. 07/133,896, filed Dec. 16, 1987, now U.S. Pat. No. 4,973,594, issued Nov. 27,1990.
Priority Data
Dec 17, 1986 [GB] 8630070 Dec 17, 1986 [GB] 8630072 Dec 17, 1986 [GB] 8630073 Mar 25, 1987 [GB] 8707174 Dec 02, 1987 [GB] 8728140
USPTO Field of Search
514/299  
Related Patents
7001900 - Azabicyclic compounds for the treatment of disease - Owned by Pfizer Inc. (New York, NY)

The invention provides compounds of Formula I: ##STR00001## wherein Azabicyclo is ##STR00002## W is a six-membered heterocyclic ring system having 1 2 nitrogen atoms or a 10-membered bicyclic-six-six-fused-ring system having up to two nitrogen atoms within either or both rings, provided that no nitrogen is at a bridge of the bicyclic-six-six-fused-ri- ng system, and further having 1 2 substitutents independently selected from R.sub.3.These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals to treat diseases or conditions in which .alpha.7 is known to be involved.

5706062 - Projector system including keystone correction - Owned by Unic View Ltd. (Herzliya,IL)

A projector for use with a light source and including a shutter assembly having a multiplicity of pixel light valves and a color separator disposed intermediate the light source and the shutter assembly and spaced therefrom and providing a plurality of spatially separated differently colored light beams, wherein the plurality of spatially separated differently colored light beams are in predetermined registration with the multiplicity of pixel light valves.

5617152 - Projector system for video and computer generated information - Owned by UNIC View Ltd. (Herzliya,IL)

A projector for use with a light source and including a shutter assembly panel having a multiplicity of pixel light valves overlying an array of interspersed shutter pixels each of which transmits only one of a plurality of colors, and a color filter disposed intermediate the light source and the planar shutter and spaced therefrom and having an array of interspersed filter pixels, each of which only transmits only one of a plurality of colors, wherein the array of interspersed filter pixels is in light and color registration with the array of interspersed shutter pixels, such that generally light of a given color impinges on a shutter area of the same color.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us